F-star Therapeutics Inc Watch

from 10-Q 2 pages Strictly Private & Confidential Louis Kayitalire Addresses 1 April 2022 Dear Louis Amendment to the Indefinite Term Employment Contract / Amendement Au Contrat De Travail À Durée Indéterminée I Am Writing to Confirm an Amendment to Your Service Agreement With Effect From 31 March 2022. / Je Vous Écris Pour Confirmer Une Modification De Votre Contrat De Service Avec Effet Au 31 Mars 2022. the Parties Hereby Agree as Follows / Les Parties Conviennent Par La Présente De Ce Qui Suit: 1. Article 17 of the Employment Contract Is Amended by Deleting the Reference To, “To the Extent Not Assumed by an Acquirer”. / L’article 18.6 Du Contrat De Travail Est Modifié en Supprimant La Référence À “Dans La Mesure Où Elle N’est Pas Assumée Par Un Acquéreur”. 2. Except as Specifically Modified Herein, Any of the Other Terms of the Agreement Shall Remain in Full Force and Effect. / Sauf Modification Expresse Dans Les Présentes, Toutes Les Autres Conditions De L’accord Resteront Pleinement en Vigueur. in Witness Whereof, the Parties Hereto Have Executed the Amendment as of the Date First Written Above. / en Foi De Quoi, Les Parties Aux Présentes Ont Exécuté L’amendement À La Date Indiquée Pour La Première Fois CI-Dessus. for F-star Therapeutics Ltd for Employee Signature: /S/ Eliot R. Forster Signature: /S/ Louis Kayitalire Name: Eliot Forster Name: Louis Kayitalire Title: CEO Title: Chief Medical Officer

from 10-Q 16 pages Material contract

from 10-Q 3 pages Dear Neil Amendment to Service Agreement for F-star Therapeutics Ltd for Employee Signature: /S/ Eliot R. Forster Signature: /S/ Neil Brewis Name: Eliot Forster Name: Neil Brewis Title: Chief Executive Officer Title: Chief Scientific Officer F-star Therapeutics Limited Eddeva B920 | Babraham Research Campus | Cambridge, Cb22 3at, Uk | T: +44 1223 497400 | WWW.F-STAR.com

from 10-Q 3 pages F-star Therapeutics Inc 245 First Street Riverview II Floor 18 Cambridge, Ma 02142 USA WWW.F-STAR.com Darlene Deptula-Hicks Crimson Consulting, LLC Addresses 6 April 2022 Dear Darlene, Amendment to Consulting Agreement

from 10-Q 3 pages Tel: +44 (0)1223 497400 Fax: +44 (0)1223 497461 Cambridge@f-Star.com F-star Therapeutics Limited Eddeva B920 Babraham Research Campus Cambridge Cb22 3at United Kingdom WWW.F-STAR.com Strictly Private & Confidential Eliot Forster Addresses 6 April 2022 Dear Eliot Amendment to Service Agreement for F-star Therapeutics Ltd for Employee Signature: /S/ Darlene Deptula-Hicks Signature: /S/ Eliot R. Forster Name: Darlene Deptula-Hicks Name: Eliot Forster Title: Chief Financial Officer Title: Chief Executive Officer F-star Therapeutics Limited Eddeva B920 | Babraham Research Campus | Cambridge, Cb22 3at, Uk | T: +44 1223 497400 | WWW.F-STAR.com

from 10-K 9 pages Restricted Share Unit Grant Notice F-star Therapeutics, Inc. 2019 Equity Incentive Plan [:Non-Employee Sub-Plan]12

from 10-K 10 pages Performance Share Unit Grant Notice F-star Therapeutics, Inc. 2019 Equity Incentive Plan [:Non-Employee Sub-Plan]8

from 10-K 11 pages Restricted Share Grant Notice F-star Therapeutics, Inc. 2019 Equity Incentive Plan [:Non-Employee Sub-Plan]4

from 10-K 8 pages F-star Therapeutics, Inc. 2019 Equity Incentive Plan [:Non- Employee Sub-Plan]1

from 10-K 24 pages Consulting Agreement

from 10-Q 95 pages Pursuant to 17 C.F.R. Section 200.83 Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Would Likely Cause Competitive Harm if Publicly Disclosed. [***] Indicates That Information Has Been Redacted. License and Collaboration Agreement Between F-star Therapeutics Limited, and Janssen Biotech, Inc. Dated as of October 19, 2021

from 10-Q 69 pages Pursuant to 17 C.F.R. Section 200.83

from 10-Q 6 pages [Pursuant to Item 601(b)(10) of Regulation S-K, Certain Confidential Portions of This Exhibit Have Been Omitted by Means of Marking Such Portions With Asterisks as the Identified Confidential Portions (I) Are Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed.]

from 10-K 41 pages Dated 14th February 2018 Babraham Bioscience Technologies Limited (1) F Star Biotechnology Limited (2) Tenancy Agreement Relating to Part of Building 522, Brian Heap Room, Riverside, Babraham Research Campus, Cambridge, Cb22 3at 1 Tenancy Agreement Index

from 10-K 31 pages Lease Agreement

from 10-K 2 pages F-star Therapeutics, Inc. Non-Employee Director Compensation Plan

from 8-K 29 pages Exsting Antagonist Contingent Value Rights Agreement

from 8-K 29 pages Contingent Value Rights Agreement

from 8-K 11 pages Indemnification Agreement

from 8-K 15 pages Employment Agreement